Literature DB >> 12135000

Use of an oil-hydraulic microinjection pump for subretinal infusions.

Judith Weichel1, Monika Valtink, Katrin Engelmann, Gisbert Richard.   

Abstract

The injection of cell suspensions or drugs into the subretinal space is a new promising option of vitreoretinal surgery for the treatment of degenerative retinal disorders. We used a manual oil-hydraulic microinjection pump to subretinally inject suspensions of retinal pigment epithelial cells in Royal College of Surgeons rats and in patients suffering from age-related macular degeneration with geographic atrophy. The histological examination of the treated rat eyes showed that cell suspensions could be placed precisely in the subretinal space. Intra- and postoperative outcome of the patients in the clinical trial revealed no retinal complications during 6 months of follow up. We suggest the oil-hydraulic microinjection pump to be a valuable instrument for controlled and precisely dosed atraumatic infusion or aspiration of small volumes of cell suspensions, fluids or drugs in vitreoretinal surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12135000

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers        ISSN: 1082-3069


  3 in total

Review 1.  Retinal pigment epithelium transplantation: concepts, challenges, and future prospects.

Authors:  P Alexander; H A J Thomson; A J Luff; A J Lotery
Journal:  Eye (Lond)       Date:  2015-06-05       Impact factor: 3.775

2.  Autologous peripheral retinal pigment epithelium translocation in patients with subfoveal neovascular membranes.

Authors:  J C van Meurs; E ter Averst; L J Hofland; P M van Hagen; C M Mooy; G S Baarsma; R W Kuijpers; T Boks; P Stalmans
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

3.  Experimental rat model for therapeutic retinal pigment epithelium transplantation--unequivocal microscopic identification of human donor cells by in situ hybridisation of human-specific Alu sequences.

Authors:  Beate Warncke; Monika Valtink; Judith Weichel; Katrin Engelmann; Hansjörg Schäfer
Journal:  Virchows Arch       Date:  2003-10-28       Impact factor: 4.064

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.